CrannMed along with their consortium partners are proud to announce that they have been awarded €2.5 Million from the Disruptive Technologies Innovation Funding (DTIF) run by the Department of Enterprise Trade and Employment and administered by Enterprise Ireland.


With this funding CrannMed and its partners are developing an innovative solution for people suffering from knee pain resulting from knee osteoarthritis.


The project will develop the feeding system to a high level of technological readiness, demonstrating its operational utility in industrially relevant applications.


The project consortium consists of three Galway based organisations: CrannMed, ICS Medical and Creganna Medical (a part of TE Connectivity), along with CREST in the Technical University of Dublin.


The consortium partners bring expertise in embolic microsphere and microcatheter delivery system design and commercialisation; state-of-the-art manufacturing; and material science. CrannMed, an innovative Medical Device company and the lead partner in the consortium, bring product design, project management and commercialisation expertise to the project. ICS Medical brings extensive expertise in contract manufacturing. TUD’s CREST is a research centre committed to supporting research, development, and innovation in the material science area. Creganna Medical brings exceptional expertise in process development and scaling technologies for high volume manufacturing.